Zurich Insurance Group (ZURN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Nov, 2026Executive summary
Record 2024 BOP of $7.8bn, up 5% year over year and 6% in local currencies; net income attributable to shareholders was $5.8bn.
Core ROE reached 24.6%; cash remittances totaled $7.1bn, and the proposed dividend rose 8% to CHF 28 per share.
All segments delivered strong results, with record P&C and Life BOP and robust Farmers profitability.
Financial highlights
Insurance revenue increased to $59.5bn from $56.1bn; net income attributable to shareholders rose to $5.8bn from $4.4bn.
Core EPS reached $40.1, with an 8% CAGR; adjusted EPS rose 10% to $42.2.
P&C gross written premiums increased 5% to $46.6bn, supported by average rate increases of 4%; Life gross premiums rose 4% in local currencies.
Insurance service result was $6.0bn versus $5.7bn; net investment result on Group investments was $6.8bn versus $4.7bn.
Outlook and guidance
2025–2027 targets include Core EPS CAGR above 9%, Core ROE above 23% by 2027, and cumulative cash remittances above $19bn; Commercial BOP target is above $4.2bn.
2025 P&C insurance revenue expected to grow at a mid-single-digit rate; Life BOP expected to remain in line with the 2024 record of $2.2bn.
Farmers Exchanges GWP expected to grow at a mid-single-digit rate; FMS MGEP margin guidance is 7.0%.
Group Functions and Operations net expenses expected at $800–850m; effective tax rate guidance is 25–27%.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - P&C underwriting gains lifted H1 BOP 16%, with combined ratio improving to 95.1%.ZURN
H1 2019 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023